The global Biodefense revenue was US$ 1144 million in 2022 and is forecast to a readjusted size of US$ 1884.2 million by 2029 with a CAGR of 7.3% during the review period (2023-2029).

and India Biodefense Market

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.

In India, the Biodefense revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.

The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.

This report focuses on global and India Biodefense market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Biodefense will continue to grow rapidly in the future.

Global Biodefense Scope and Market Size

Biodefense market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biodefense market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.

For India market, this report focuses on the Biodefense market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Biodefense Market Report

Report Metric	Details
Report Name	and India Biodefense Market
Forecasted market size in 2029	US$ 1884.2 million
CAGR	7.3%
Forecasted years	2023 - 2029
Segment by Type	Anthrax Smallpox Botulism Radiation/Nuclear Others
Segment by Application	US Military Market US Civilian Market Non - US Market
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeutics, Dynavax Technologies, Cleveland BioLabs, Soligenix, Alnylam Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Biodefense Market size in 2029?

Ans: The and India Biodefense Market size in 2029 will be US$ 1884.2 million.

What is the market share of major companies in and India Biodefense Market?

Ans: The top 3 players occupy about 60% shares of the global market.

What is the and India Biodefense Market share by type?

Ans: Anthrax and Smallpox are main types, with a share about 70%.

What is the and India Biodefense Market share by application?

Ans: US Civilian Market is the main application, which holds a share about 55%.

What is the and India Biodefense Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Biodefense Market report?

Ans: The main players in the and India Biodefense Market are Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma, DynPort Vaccine, Xoma Corporation, Ichor Medical Systems, Aeolus Pharmaceuticals, Achaogen, Elusys Therapeutics, Dynavax Technologies, Cleveland BioLabs, Soligenix, Alnylam Pharmaceuticals

What are the Application segmentation covered in the and India Biodefense Market report?

Ans: The Applications covered in the and India Biodefense Market report are US Military Market, US Civilian Market, Non - US Market

What are the Type segmentation covered in the and India Biodefense Market report?

Ans: The Types covered in the and India Biodefense Market report are Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others

1 Study Coverage

1.1 Biodefense Product Introduction

1.2 Global Biodefense Outlook 2018 VS 2022 VS 2029

1.2.1 Global Biodefense Market Size for the Year 2018-2029

1.2.2 India Biodefense Market Size for the Year 2018-2029

1.3 Biodefense Market Size, India VS Global, 2018 VS 2022 VS 2029

1.3.1 The Market Share of India Biodefense in Global, 2018 VS 2022 VS 2029

1.3.2 The Growth Rate of Biodefense Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4 Biodefense Market Dynamics

1.4.1 Biodefense Industry Trends

1.4.2 Biodefense Market Drivers

1.4.3 Biodefense Market Challenges

1.4.4 Biodefense Market Restraints

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Biodefense by Type

2.1 Biodefense Market Segment by Type

2.1.1 Anthrax

2.1.2 Smallpox

2.1.3 Botulism

2.1.4 Radiation/Nuclear

2.1.5 Others

2.2 Global Biodefense Market Size by Type (2018, 2022 & 2029)

2.3 Global Biodefense Market Size by Type (2018-2029)

2.4 India Biodefense Market Size by Type (2018, 2022 & 2029)

2.5 India Biodefense Market Size by Type (2018-2029)

3 Biodefense by Application

3.1 Biodefense Market Segment by Application

3.1.1 US Military Market

3.1.2 US Civilian Market

3.1.3 Non - US Market

3.2 Global Biodefense Market Size by Application (2018, 2022 & 2029)

3.3 Global Biodefense Market Size by Application (2018-2029)

3.4 India Biodefense Market Size by Application (2018, 2022 & 2029)

3.5 India Biodefense Market Size by Application (2018-2029)

4 Global Biodefense Competitor Landscape by Company

4.1 Global Biodefense Market Size by Company

4.1.1 Global Key Companies of Biodefense, Ranked by Revenue (2022)

4.1.2 Global Biodefense Revenue by Player (2018-2023)

4.2 Global Biodefense Concentration Ratio (CR)

4.2.1 Biodefense Market Concentration Ratio (CR) (2018-2023)

4.2.2 Global Top 5 and Top 10 Largest Companies of Biodefense in 2022

4.2.3 Global Biodefense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Players of Biodefense Head office and Area Served

4.4 Global Key Players of Biodefense, Product and Application

4.5 Global Key Players of Biodefense, Date of Enter into This Industry

4.6 Companies Mergers & Acquisitions, Expansion Plans

4.7 India Biodefense Market Size by Company

4.7.1 Key Players of Biodefense in India, Ranked by Revenue (2022)

4.7.2 India Biodefense Revenue by Players (2021, 2022 & 2023)

5 Global Biodefense Market Size by Region

5.1 Global Biodefense Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Biodefense Market Size by Region (2018-2029)

5.2.1 Global Biodefense Market Size by Region: 2018-2023

5.2.2 Global Biodefense Market Size by Region (2024-2029)

6 Americas

6.1 Americas Biodefense Market Size YoY Growth 2018-2029

6.2 Americas Biodefense Market Size by Type

6.2.1 Americas Biodefense Market Size by Type (2018-2023)

6.2.2 Americas Biodefense Market Size by Type (2024-2029)

6.2.3 Americas Biodefense Market Share by Type (2018-2029)

6.3 Americas Biodefense Market Size by Application

6.3.1 Americas Biodefense Market Size by Application (2018-2023)

6.3.2 Americas Biodefense Market Size by Application (2024-2029)

6.3.3 Americas Biodefense Market Share by Application (2018-2029)

6.4 Americas Biodefense Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 United States

6.4.2 Canada

6.4.3 Mexico

6.4.4 Brazil

7 EMEA

7.1 EMEA Biodefense Market Size YoY Growth 2018-2029

7.2 EMEA Biodefense Market Size by Type

7.2.1 EMEA Biodefense Market Size by Type (2018-2023)

7.2.2 EMEA Biodefense Market Size by Type (2024-2029)

7.2.3 EMEA Biodefense Market Share by Type (2018-2029)

7.3 EMEA Biodefense Market Size by Application

7.3.1 EMEA Biodefense Market Size by Application (2018-2023)

7.3.2 EMEA Biodefense Market Size by Application (2024-2029)

7.3.3 EMEA Biodefense Market Share by Application (2018-2029)

7.4 EMEA Biodefense Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 Europe

7.4.2 Middle East

7.4.3 Africa

8 China

8.1 China Biodefense Market Size YoY Growth 2018-2029

8.2 China Biodefense Market Size by Type

8.2.1 China Biodefense Market Size by Type (2018-2023)

8.2.2 China Biodefense Market Size by Type (2024-2029)

8.2.3 China Biodefense Market Share by Type (2018-2029)

8.3 China Biodefense Market Size by Application

8.3.1 China Biodefense Market Size by Application (2018-2023)

8.3.2 China Biodefense Market Size by Application (2024-2029)

8.3.3 China Biodefense Market Share by Application (2018-2029)

9 APAC (excluding China)

9.1 APAC Biodefense Market Size YoY Growth 2018-2029

9.2 APAC Biodefense Market Size by Type

9.2.1 APAC Biodefense Market Size by Type (2018-2023)

9.2.2 APAC Biodefense Market Size by Type (2024-2029)

9.2.3 APAC Biodefense Market Share by Type (2018-2029)

9.3 APAC Biodefense Market Size by Application

9.3.1 APAC Biodefense Market Size by Application (2018-2023)

9.3.2 APAC Biodefense Market Size by Application (2024-2029)

9.3.3 APAC Biodefense Market Share by Application (2018-2029)

9.4 APAC Biodefense Market Facts & Figures by Country (2018, 2022 & 2029)

9.4.1 Japan

9.4.2 South Korea

9.4.3 China Taiwan

9.4.4 Southeast Asia

9.4.5 India

10 Key Players Profiles

10.1 Emergent Biosolutions

10.1.1 Emergent Biosolutions Company Details

10.1.2 Emergent Biosolutions Business Overview

10.1.3 Emergent Biosolutions Biodefense Introduction

10.1.4 Emergent Biosolutions Revenue in Biodefense Business (2018-2023)

10.1.5 Emergent Biosolutions Recent Development

10.2 Hytest

10.2.1 Hytest Company Details

10.2.2 Hytest Business Overview

10.2.3 Hytest Biodefense Introduction

10.2.4 Hytest Revenue in Biodefense Business (2018-2023)

10.2.5 Hytest Recent Development

10.3 GSK

10.3.1 GSK Company Details

10.3.2 GSK Business Overview

10.3.3 GSK Biodefense Introduction

10.3.4 GSK Revenue in Biodefense Business (2018-2023)

10.3.5 GSK Recent Development

10.4 Sanofi

10.4.1 Sanofi Company Details

10.4.2 Sanofi Business Overview

10.4.3 Sanofi Biodefense Introduction

10.4.4 Sanofi Revenue in Biodefense Business (2018-2023)

10.4.5 Sanofi Recent Development

10.5 PharmAthene

10.5.1 PharmAthene Company Details

10.5.2 PharmAthene Business Overview

10.5.3 PharmAthene Biodefense Introduction

10.5.4 PharmAthene Revenue in Biodefense Business (2018-2023)

10.5.5 PharmAthene Recent Development

10.6 Bavarian Nordic

10.6.1 Bavarian Nordic Company Details

10.6.2 Bavarian Nordic Business Overview

10.6.3 Bavarian Nordic Biodefense Introduction

10.6.4 Bavarian Nordic Revenue in Biodefense Business (2018-2023)

10.6.5 Bavarian Nordic Recent Development

10.7 SIGA Technologies

10.7.1 SIGA Technologies Company Details

10.7.2 SIGA Technologies Business Overview

10.7.3 SIGA Technologies Biodefense Introduction

10.7.4 SIGA Technologies Revenue in Biodefense Business (2018-2023)

10.7.5 SIGA Technologies Recent Development

10.8 Arbutus Biopharma

10.8.1 Arbutus Biopharma Company Details

10.8.2 Arbutus Biopharma Business Overview

10.8.3 Arbutus Biopharma Biodefense Introduction

10.8.4 Arbutus Biopharma Revenue in Biodefense Business (2018-2023)

10.8.5 Arbutus Biopharma Recent Development

10.9 DynPort Vaccine

10.9.1 DynPort Vaccine Company Details

10.9.2 DynPort Vaccine Business Overview

10.9.3 DynPort Vaccine Biodefense Introduction

10.9.4 DynPort Vaccine Revenue in Biodefense Business (2018-2023)

10.9.5 DynPort Vaccine Recent Development

10.10 Xoma Corporation

10.10.1 Xoma Corporation Company Details

10.10.2 Xoma Corporation Business Overview

10.10.3 Xoma Corporation Biodefense Introduction

10.10.4 Xoma Corporation Revenue in Biodefense Business (2018-2023)

10.10.5 Xoma Corporation Recent Development

10.11 Ichor Medical Systems

10.11.1 Ichor Medical Systems Company Details

10.11.2 Ichor Medical Systems Business Overview

10.11.3 Ichor Medical Systems Biodefense Introduction

10.11.4 Ichor Medical Systems Revenue in Biodefense Business (2018-2023)

10.11.5 Ichor Medical Systems Recent Development

10.12 Aeolus Pharmaceuticals

10.12.1 Aeolus Pharmaceuticals Company Details

10.12.2 Aeolus Pharmaceuticals Business Overview

10.12.3 Aeolus Pharmaceuticals Biodefense Introduction

10.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2018-2023)

10.12.5 Aeolus Pharmaceuticals Recent Development

10.13 Achaogen

10.13.1 Achaogen Company Details

10.13.2 Achaogen Business Overview

10.13.3 Achaogen Biodefense Introduction

10.13.4 Achaogen Revenue in Biodefense Business (2018-2023)

10.13.5 Achaogen Recent Development

10.14 Elusys Therapeutics

10.14.1 Elusys Therapeutics Company Details

10.14.2 Elusys Therapeutics Business Overview

10.14.3 Elusys Therapeutics Biodefense Introduction

10.14.4 Elusys Therapeutics Revenue in Biodefense Business (2018-2023)

10.14.5 Elusys Therapeutics Recent Development

10.15 Dynavax Technologies

10.15.1 Dynavax Technologies Company Details

10.15.2 Dynavax Technologies Business Overview

10.15.3 Dynavax Technologies Biodefense Introduction

10.15.4 Dynavax Technologies Revenue in Biodefense Business (2018-2023)

10.15.5 Dynavax Technologies Recent Development

10.16 Cleveland BioLabs

10.16.1 Cleveland BioLabs Company Details

10.16.2 Cleveland BioLabs Business Overview

10.16.3 Cleveland BioLabs Biodefense Introduction

10.16.4 Cleveland BioLabs Revenue in Biodefense Business (2018-2023)

10.16.5 Cleveland BioLabs Recent Development

10.17 Soligenix

10.17.1 Soligenix Company Details

10.17.2 Soligenix Business Overview

10.17.3 Soligenix Biodefense Introduction

10.17.4 Soligenix Revenue in Biodefense Business (2018-2023)

10.17.5 Soligenix Recent Development

10.18 Alnylam Pharmaceuticals

10.18.1 Alnylam Pharmaceuticals Company Details

10.18.2 Alnylam Pharmaceuticals Business Overview

10.18.3 Alnylam Pharmaceuticals Biodefense Introduction

10.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2018-2023)

10.18.5 Alnylam Pharmaceuticals Recent Development

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.2 Data Source

12.2 Disclaimer

12.3 Author Details

FEATURED COMPANIES

Government

Emergent Biosolutions

Ichor Medical Systems

Aeolus Pharmaceuticals

Alnylam Pharmaceuticals

List of Tables

Table 1. Biodefense Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)

Table 2. Biodefense Market Trends

Table 3. Biodefense Market Drivers

Table 4. Biodefense Market Challenges

Table 5. Biodefense Market Restraints

Table 6. Global Biodefense Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Biodefense Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Biodefense Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Biodefense Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Companies of Biodefense, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Biodefense Revenue by Player, (US$ Million), 2018-2023

Table 12. Global Biodefense Revenue Share by Player, 2018-2023

Table 13. Global Biodefense Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global Biodefense by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2022)

Table 15. Global Key Players of Biodefense, Headquarters and Area Served

Table 16. Global Key Players of Biodefense, Product and Application

Table 17. Global Key Players of Biodefense, Date of Enter into This Industry

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Key Players of Biodefense in India, Ranked by Revenue (2022) & (US$ Million)

Table 20. India Biodefense Revenue by Players, (US$ Million), 2021, 2022 & 2023

Table 21. India Biodefense Revenue Share by Players, 2021, 2022 & 2023

Table 22. Global Biodefense Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 23. Global Biodefense Market Size by Region (2018-2023) & (US$ Million)

Table 24. Global Biodefense Market Size Forecast by Region (2024-2029) & (US$ Million)

Table 25. Americas Biodefense Market Size by Type (2018-2023) & (US$ Million)

Table 26. Americas Biodefense Market Size by Type (2024-2029) & (US$ Million)

Table 27. Americas Biodefense Market Size by Application (2018-2023) & (US$ Million)

Table 28. Americas Biodefense Market Size by Application (2024-2029) & (US$ Million)

Table 29. Americas Biodefense Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 30. Americas Biodefense Market Size by Country (2018-2023) & (US$ Million)

Table 31. Americas Biodefense Market Size by Country (2024-2029) & (US$ Million)

Table 32. EMEA Biodefense Market Size by Type (2018-2023) & (US$ Million)

Table 33. EMEA Biodefense Market Size by Type (2024-2029) & (US$ Million)

Table 34. EMEA Biodefense Market Size by Application (2018-2023) & (US$ Million)

Table 35. EMEA Biodefense Market Size by Application (2024-2029) & (US$ Million)

Table 36. EMEA Biodefense Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. EMEA Biodefense Market Size by Country (2018-2023) & (US$ Million)

Table 38. EMEA Biodefense Market Size by Country (2024-2029) & (US$ Million)

Table 39. China Biodefense Market Size by Type (2018-2023) & (US$ Million)

Table 40. China Biodefense Market Size by Type (2024-2029) & (US$ Million)

Table 41. China Biodefense Market Size by Application (2018-2023) & (US$ Million)

Table 42. China Biodefense Market Size by Application (2024-2029) & (US$ Million)

Table 43. China Biodefense Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. APAC Biodefense Market Size by Type (2018-2023) & (US$ Million)

Table 45. APAC Biodefense Market Size by Type (2024-2029) & (US$ Million)

Table 46. APAC Biodefense Market Size by Application (2018-2023) & (US$ Million)

Table 47. APAC Biodefense Market Size by Application (2024-2029) & (US$ Million)

Table 48. APAC Biodefense Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 49. APAC Biodefense Market Size by Region (2018-2023) & (US$ Million)

Table 50. APAC Biodefense Market Size by Region (2024-2029) & (US$ Million)

Table 51. Emergent Biosolutions Company Details

Table 52. Emergent Biosolutions Business Overview

Table 53. Emergent Biosolutions Biodefense Product

Table 54. Emergent Biosolutions Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 55. Emergent Biosolutions Recent Development

Table 56. Hytest Company Details

Table 57. Hytest Business Overview

Table 58. Hytest Biodefense Product

Table 59. Hytest Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 60. Hytest Recent Development

Table 61. GSK Company Details

Table 62. GSK Business Overview

Table 63. GSK Biodefense Product

Table 64. GSK Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 65. GSK Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi Biodefense Product

Table 69. Sanofi Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. PharmAthene Company Details

Table 72. PharmAthene Business Overview

Table 73. PharmAthene Biodefense Product

Table 74. PharmAthene Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 75. PharmAthene Recent Development

Table 76. Bavarian Nordic Company Details

Table 77. Bavarian Nordic Business Overview

Table 78. Bavarian Nordic Biodefense Product

Table 79. Bavarian Nordic Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 80. Bavarian Nordic Recent Development

Table 81. SIGA Technologies Company Details

Table 82. SIGA Technologies Business Overview

Table 83. SIGA Technologies Biodefense Product

Table 84. SIGA Technologies Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 85. SIGA Technologies Recent Development

Table 86. Arbutus Biopharma Company Details

Table 87. Arbutus Biopharma Business Overview

Table 88. Arbutus Biopharma Biodefense Product

Table 89. Arbutus Biopharma Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 90. Arbutus Biopharma Recent Development

Table 91. DynPort Vaccine Company Details

Table 92. DynPort Vaccine Business Overview

Table 93. DynPort Vaccine Biodefense Product

Table 94. DynPort Vaccine Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 95. DynPort Vaccine Recent Development

Table 96. Xoma Corporation Company Details

Table 97. Xoma Corporation Business Overview

Table 98. Xoma Corporation Biodefense Product

Table 99. Xoma Corporation Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 100. Xoma Corporation Recent Development

Table 101. Ichor Medical Systems Company Details

Table 102. Ichor Medical Systems Business Overview

Table 103. Ichor Medical Systems Biodefense Product

Table 104. Ichor Medical Systems Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 105. Ichor Medical Systems Recent Development

Table 106. Aeolus Pharmaceuticals Company Details

Table 107. Aeolus Pharmaceuticals Business Overview

Table 108. Aeolus Pharmaceuticals Biodefense Product

Table 109. Aeolus Pharmaceuticals Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 110. Aeolus Pharmaceuticals Recent Development

Table 111. Achaogen Company Details

Table 112. Achaogen Business Overview

Table 113. Achaogen Biodefense Product

Table 114. Achaogen Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 115. Achaogen Recent Development

Table 116. Elusys Therapeutics Company Details

Table 117. Elusys Therapeutics Business Overview

Table 118. Elusys Therapeutics Biodefense Product

Table 119. Elusys Therapeutics Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 120. Elusys Therapeutics Recent Development

Table 121. Dynavax Technologies Company Details

Table 122. Dynavax Technologies Business Overview

Table 123. Dynavax Technologies Biodefense Product

Table 124. Dynavax Technologies Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 125. Dynavax Technologies Recent Development

Table 126. Cleveland BioLabs Company Details

Table 127. Cleveland BioLabs Business Overview

Table 128. Cleveland BioLabs Biodefense Product

Table 129. Cleveland BioLabs Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 130. Cleveland BioLabs Recent Development

Table 131. Soligenix Company Details

Table 132. Soligenix Business Overview

Table 133. Soligenix Biodefense Product

Table 134. Soligenix Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 135. Soligenix Recent Development

Table 136. Alnylam Pharmaceuticals Company Details

Table 137. Alnylam Pharmaceuticals Business Overview

Table 138. Alnylam Pharmaceuticals Biodefense Product

Table 139. Alnylam Pharmaceuticals Revenue in Biodefense Business (2018-2023) & (US$ Million)

Table 140. Alnylam Pharmaceuticals Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Biodefense Product Picture

Figure 2. Global Biodefense Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Biodefense Market Size 2018-2029 (US$ Million)

Figure 4. India Biodefense Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 5. India Biodefense Market Size 2018-2029 (US$ Million)

Figure 6. India Biodefense Market Share in Global 2018-2029

Figure 7. Biodefense Report Years Considered

Figure 8. Product Picture of Anthrax

Figure 9. Product Picture of Smallpox

Figure 10. Product Picture of Botulism

Figure 11. Product Picture of Radiation/Nuclear

Figure 12. Product Picture of Others

Figure 13. Global Biodefense Market Share by Type in 2022 & 2029

Figure 14. Global Biodefense Market Size by Type (2018-2029) & (US$ Million)

Figure 15. Global Biodefense Market Share by Type (2018-2029)

Figure 16. India Biodefense Market Share by Type in 2022 & 2029

Figure 17. India Biodefense Market Size by Type (2018-2029) & (US$ Million)

Figure 18. India Biodefense Market Share by Type (2018-2029)

Figure 19. Product Picture of US Military Market

Figure 20. Product Picture of US Civilian Market

Figure 21. Product Picture of Non - US Market

Figure 22. Global Biodefense Market Share by Application in 2022 & 2029

Figure 23. Global Biodefense Market Size by Application (2018-2029) & (US$ Million)

Figure 24. Global Biodefense Market Share by Application (2018-2029)

Figure 25. India Biodefense Market Share by Application in 2022 & 2029

Figure 26. India Biodefense Market Size by Application (2018-2029) & (US$ Million)

Figure 27. India Biodefense Market Share by Application (2018-2029)

Figure 28. The Top 5 and 10 Largest Companies of Biodefense in the World: Market Share by Biodefense Revenue in 2022

Figure 29. Global Biodefense Market Size Market Share by Region: 2018 VS 2022 VS 2029

Figure 30. Global Biodefense Market Share by Region (2018-2029)

Figure 31. Americas Biodefense Market Size Growth Rate 2018-2029 (US$ Million)

Figure 32. Americas Biodefense Market Share by Type (2018-2029)

Figure 33. Americas Biodefense Market Share by Application (2018-2029)

Figure 34. United States Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 35. Canada Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 36. Mexico Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 37. Brazil Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 38. EMEA Biodefense Market Size Growth Rate 2018-2029 (US$ Million)

Figure 39. EMEA Biodefense Market Share by Type (2018-2029)

Figure 40. EMEA Biodefense Market Share by Application (2018-2029)

Figure 41. Europe Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 42. Middle East Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 43. Africa Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 44. China Biodefense Market Size Growth Rate 2018-2029 (US$ Million)

Figure 45. China Biodefense Market Share by Type (2018-2029)

Figure 46. China Biodefense Market Share by Application (2018-2029)

Figure 47. APAC Biodefense Market Size Growth Rate 2018-2029 (US$ Million)

Figure 48. APAC Biodefense Market Share by Type (2018-2029)

Figure 49. APAC Biodefense Market Share by Application (2018-2029)

Figure 50. Japan Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 51. South Korea Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 52. China Taiwan Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 53. Southeast Asia Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 54. India Biodefense Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 55. Emergent Biosolutions Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 56. Hytest Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 57. GSK Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 58. Sanofi Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 59. PharmAthene Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 60. Bavarian Nordic Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 61. SIGA Technologies Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 62. Arbutus Biopharma Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 63. DynPort Vaccine Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 64. Xoma Corporation Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 65. Ichor Medical Systems Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 66. Aeolus Pharmaceuticals Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 67. Achaogen Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 68. Elusys Therapeutics Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 69. Dynavax Technologies Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 70. Cleveland BioLabs Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 71. Soligenix Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 72. Alnylam Pharmaceuticals Revenue Growth Rate in Biodefense Business (2018-2023)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19T20220

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33H20007

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10G20315

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Zirconium Tetrachloride Precursor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36N20019

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global and India Biodefense Market Report & Forecast 2023-2029

Published Date: November 2023

Report Code: QYRE-Auto-30B15639

Global and India Biodefense Market Report & Forecast 2023-2029

FEATURED COMPANIES

and India Biodefense Market Size

and India Biodefense Market

Scope of and India Biodefense Market Report

FAQ for this report

What is the and India Biodefense Market size in 2029?

What is the market share of major companies in and India Biodefense Market?

What is the and India Biodefense Market share by type?

What is the and India Biodefense Market share by application?

What is the and India Biodefense Market share by region?

Who are the main players in the and India Biodefense Market report?

What are the Application segmentation covered in the and India Biodefense Market report?

What are the Type segmentation covered in the and India Biodefense Market report?

FEATURED COMPANIES

RELATED REPORTS